Milvexian
Clinical data | |
---|---|
Other names | BMS-986177, JNJ-70033093 |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 11.4–18.1 h[1] |
Identifiers | |
| |
JSmol) | |
| |
|
Milvexian is a
References
- S2CID 237617815.
- S2CID 244132392.
- ^ "A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (AXIOMATIC-SSP)". ClinicalTrial.gov. U.S. National Library of Medicine. Retrieved 26 June 2023.